Form 4: Paychex Chairman Martin Mucci Reports Significant Stock Option Exercises and Share Sales
Insider Transaction Report
Paychex Chairman Martin Mucci reported the exercise of stock options and subsequent sale of shares, including tax-related dispositions, resulting in a net increase in his direct beneficial ownership.
Summary
- Martin Mucci, Chairman and Director of Paychex Inc. (PAYX), reported multiple transactions on July 10, 2025.
- He exercised stock options to acquire a total of 435,226 shares of common stock at an exercise price of $60.84 per share.
- Concurrently, he disposed of 310,700 shares at weighted average prices of $145.55 and $145.62 to cover tax withholding obligations related to the option exercises.
- Additionally, he sold 97,526 shares in the open market at a weighted average price of $145.17, with prices ranging from $145.00 to $145.54.
- Following these transactions, Mucci's direct beneficial ownership of Paychex common stock stands at 446,917.3318 shares.
- The net effect of these reported transactions was an increase of 27,000 shares in his direct beneficial ownership.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive due to the net increase in the reporting person's direct beneficial ownership, indicating continued investment in the company, despite some shares being sold for tax purposes and liquidity.
Positives
- Exercise of 435,226 stock options indicates the realization of value from long-term incentives.
- A net increase of 27,000 shares in direct beneficial ownership after all reported transactions, suggesting continued alignment with shareholder interests.
Negatives
- Sale of 97,526 shares in the open market, which could be interpreted as a reduction in personal exposure.
- Disposition of 310,700 shares for tax withholding purposes, reducing the total number of shares held directly.
Future Outlook
This Form 4 filing reports past transactions and does not contain forward-looking statements or guidance regarding the company's future performance.
Industry Context
This filing details specific insider trading activity for Paychex Inc. and does not provide broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: May interpret the net increase in direct holdings as a positive signal of management's continued alignment with shareholder interests, while the open market sale might be viewed neutrally as a liquidity event.
Key Dates
| Date | Description |
|---|---|
| 07/06/2017 | Date exercisable for stock options with an exercise price of $60.84. |
| 07/12/2018 | Date exercisable for stock options with an exercise price of $57.24. |
| 07/11/2019 | Date exercisable for stock options with an exercise price of $69.54. |
| 07/10/2020 | Date exercisable for stock options with an exercise price of $85.46. |
| 07/15/2021 | Date exercisable for stock options with an exercise price of $73.53. |
| 07/15/2022 | Date exercisable for stock options with an exercise price of $112.67. |
| 10/15/2023 | Date exercisable for stock options with an exercise price of $109.19. |
| 07/15/2024 | Date exercisable for stock options with an exercise price of $120.86. |
| 07/10/2025 | Date of reported transactions (stock option exercises, tax-related dispositions, and open market sales). |
| 07/11/2025 | Signature date of the Form 4 filing. |
| 07/15/2025 | Date exercisable for stock options with an exercise price of $121.63. |
| 07/05/2026 | Expiration date for stock options with an exercise price of $60.84. |
| 07/11/2027 | Expiration date for stock options with an exercise price of $57.24. |
| 07/10/2028 | Expiration date for stock options with an exercise price of $69.54. |
| 07/09/2029 | Expiration date for stock options with an exercise price of $85.46. |
| 07/14/2030 | Expiration date for stock options with an exercise price of $73.53. |
| 07/14/2031 | Expiration date for stock options with an exercise price of $112.67. |
| 10/14/2032 | Expiration date for stock options with an exercise price of $109.19. |
| 07/14/2033 | Expiration date for stock options with an exercise price of $120.86. |
| 07/14/2034 | Expiration date for stock options with an exercise price of $121.63. |
Keywords
Paychex, PAYX, Form 4, insider trading, stock options, beneficial ownership, Martin Mucci, Chairman, Director, stock sale, stock acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.